These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9013282)

  • 1. The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats.
    Kim KH; Lee MG; Kim DG
    Int J Pancreatol; 1996 Dec; 20(3):205-11. PubMed ID: 9013282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the specific cholecystokinin antagonist L 364,718 in experimental acute pancreatitis in the rat.
    Sjövall S; Ahrén B; Stenram U
    Eur Surg Res; 1988; 20(5-6):325-9. PubMed ID: 2465158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
    Jia D; Yamamoto M; Otsuki M
    World J Gastroenterol; 2015 Jul; 21(25):7742-53. PubMed ID: 26167074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats.
    Ito H; Sogabe H; Kuno M; Satoh Y; Ogawa T; Konishi K; Yoshida K
    Pancreas; 1998 Oct; 17(3):295-300. PubMed ID: 9788545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
    Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
    J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
    Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
    Watanabe S; Takeuchi T; Chey WY
    Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
    Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
    Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats.
    Wisner JR; Renner IG
    Pancreas; 1988; 3(2):174-9. PubMed ID: 2453874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
    Varga G; Scarpignato C
    Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
    Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
    Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
    Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat.
    Raboin SJ; Reeve JR; Cooper MS; Green GM; Sayegh AI
    Regul Pept; 2008 Oct; 150(1-3):73-80. PubMed ID: 18620003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recovery of acute pancreatitis depends on the enzyme amount stored in zymogen granules at early stages.
    Manso MA; García-Montero AC; Tabernero MD; Orfao A; De Dios I
    Mol Cell Biochem; 1999 Oct; 200(1-2):35-41. PubMed ID: 10569181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in both the membrane and the enzyme content of individual zymogen granules are associated with sodium taurocholate-induced pancreatitis in rats.
    Manso MA; Orfao A; Tabernero MD; Vicente S; de Dios I
    Clin Sci (Lond); 1998 Mar; 94(3):293-301. PubMed ID: 9616264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.